Open access
Sep 2026
TLR8 Stimulation Leads to Microenvironment Activation and Enhanced Antibody-Dependent Cellular Responses in CLL
Results suggest that TLR8 agonists may help counteract the suppressed phenotypes of immune effector cells and may enhance the efficacy of antibody therapy for CLL.
Giovanna Merchand-Reyes, Gauri Anyarambhatla, Maria L. Valencia Pena et al.
· International Journal of Mol... · 0 citations